tradingkey.logo

Hamlet Biopharma Announces Completion Of Alpha1h Phase Ii Study In Non-Muscle Invasive Bladder Cancer

ReutersAug 21, 2025 11:27 AM

- Hamlet BioPharma AB HAMLETb.TE:

  • HAMLET BIOPHARMA ANNOUNCES COMPLETION OF ALPHA1H PHASE II STUDY IN NON-MUSCLE INVASIVE BLADDER CANCER

  • HAMLET BIOPHARMA AB: ALL PRIMARY & SECONDARY ENDPOINTS OF SAFETY & EFFICACY WERE REACHED

Further company coverage: [HAMLETb.TE]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

Tradingkey
KeyAI